ORIGINAL RESEARCH article

Front. Immunol.

Sec. Multiple Sclerosis and Neuroimmunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1455994

This article is part of the Research TopicRemedying the injured brain in cognitive impairment: potential neuroimmune communication signaling and therapeutic opportunitiesView all 6 articles

Chronic ethanol administration exacerbates memory loss by modification of N6 methyl-adenosine mediated epigenetic signaling

Provisionally accepted
Yuanhang  LiaoYuanhang Liao1Fu  XuFu Xu1Yuqing  YanYuqing Yan1Sicheng  ZhouSicheng Zhou1,2Na  LiuNa Liu2Baomin  DouBaomin Dou1Nivetha  SrinivasanNivetha Srinivasan1Weizheng  WangWeizheng Wang1Xiongwei  ZhuXiongwei Zhu3Jiang  Hong YeJiang Hong Ye1Ying  XuYing Xu1*
  • 1Rutgers University, Newark, Newark, United States
  • 2Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, United States
  • 3Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States

The final, formatted version of the article will be published soon.

Background: Chronic alcohol use disorder (AUD) is recognized as one of the most critical risk factors for the progression of Alzheimer's disease (AD). Epigenetic and neuroimmune alterations are closely associated with the development of memory impairment related to AUD and AD.Methods: Adult APP/PS1 transgenic mice received intermittently intraperitoneal injections of ethanol (EtOH, 2.5 g/kg, i.p.) or vehicle with two "drug" treatment days, and one and two "drug-free" days every 7 days for 10 weeks. The novel object recognition (NOR) and Y-maze tests were performed to determine whether chronic ethanol treatment exacerbated memory impairment in these mice. The brain tissues were collected for pathological changes through MeRIP / RNA-sequence analyses and molecular biological assays.The results suggested that chronic intermittent ethanol (CIE) treatment for 10 weeks exacerbated sporadic and spatial memory deficits in NOR and Y-maze tests in the APP/PS1 mice. The pathological assays revealed that CIE procedure increased Aβ plaque burden in the brain of the AD mice, which were consistent with memory behavioral deficits. The subsequent MeRIP /RNA sequence analyses showed that two genes, e.g. Rbm15b and Hnrnpa2b1, were related to N6-methyladenosine (m 6 A) methylation that plays an important role in the development of memory loss.These results were further supported by molecular biological and mRNA-microRNA-lncRNA ceRNA network analyses that demonstrated that the increased Rbm15b and decreased Hnrnpa2b1 were involved in synaptic dysfunction and neuroinflammation in CIE-induced memory impairment in these AD mice.The conclusion drawn is that m 6 A mediated epigenetic dysfunction and immune cells infiltration participate in chronic alcohol use disorder related memory loss in AD mice.

Keywords: MeRIP /RNA sequence, m 6 A modulation, epigenetics, immune cells infiltration, Chronic Intermittent Ethanol

Received: 27 Jun 2024; Accepted: 28 May 2025.

Copyright: © 2025 Liao, Xu, Yan, Zhou, Liu, Dou, Srinivasan, Wang, Zhu, Ye and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ying Xu, Rutgers University, Newark, Newark, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.